Prochon Biotech Ltd.

The company focuses on development of innovative therapies in regenerative medicine and orthopaedics.

Privately held biotech company. Strategic partners include several leading Israelin institutions, but also European and American partners like MTF, Norphosys AG, Harvard, NIH. Part of Israrelian Consortium for Cell Therapy.

Avner Yayon, MD, PhD, Prof., CEO, CSO
Eyal Neria, PhD, Head of R&D
Myriam Golembo, PhD, Head Skeletal Biology & Repair
Neomi Weissblum, CPA, Director of Finance

Michael Lewis, Chairman
Philip Press, Dr.
Avner Yayon, MD, PhD, Prof.
Eli Hazum, PhD, Prof.
Tsvi Kan-Tor
Bruce W. Stroever

Bjorn Olsen, MD, PhD, Prof.
William Horton, MD, Prof.

Weizmann Science Park
2 Holzmann Street
4th Floor
Rehovot
Israel

Postal Adress:

P.O. Box 1482
76114 Rehovot
Israel

Phone: +972-8-9310900
Fax: +972-8-9318848

The company has proprietary core technologies in skeletal disorders, CNS, cardiovascular diseases and wound repair. The company’s lead product, BioCart™ combines autologous chondrocytes with a biocompatible scaffold. The company owns and licenses 11 patent families.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.